The fetal time period is a critical window of immune system development [@b1]--[@b3]. *In utero* perturbations to the regulation of immune responses and inflammatory mediators may underlie susceptibility to childhood allergic diseases. This susceptibility may manifest as alterations in fetal antibody and cytokine levels [@b4]. Previous research into biomarkers of childhood allergic disease has primarily focused on elevated levels of cord blood immunoglobulin E (IgE) and T cell-derived cytokines [@b5]--[@b8]. Recent research has demonstrated that the epithelial cell produced cytokines, thymic stromal lymphopoietin (TSLP), and interleukin-33 (IL-33) contribute to inflammatory-related conditions [@b9]. TSLP has been implicated in atopic dermatitis [@b10], eosinophilic esophagitis [@b11], and allergic airway disease [@b12]. A recent clinical trial of children treated with anti-TSLP antibodies demonstrated that, compared to controls, treated children had less bronchoconstriction and airway inflammation following an allergen challenge test [@b12]. IL-33 has been implicated in atopic dermatitis [@b13], asthma [@b14], and inflammatory bowel disease [@b15]. Neither TSLP nor IL-33, however, has been studied in neonates.

Although most research has examined the independent roles of these cytokines, the interaction between TSLP and IL-33 can exacerbate inflammatory responses. Specifically, IL-33 can induce TSLP and sensitize mast cells to TSLP. TSLP can, in conjunction with IL-33, induce mast cell production of Th2 cytokines [@b9]. Despite this experimental evidence, there is a lack of knowledge regarding the correlation of these cytokines in the developing immune system. Investigation into this correlation may provide insight into early life origins of IL-33 and TSLP cross-regulation. Mechanistic interaction between these cytokines *in utero* could potentially promote an allergic phenotype in childhood.

In recognition of evidence regarding (i) the inflammatory roles of TSLP and IL-33 and (ii) the fetal time period as a critical window of immune system development, we sought to explore the nature of these cytokines at birth. The specific objectives of this exploratory analysis were to: (i) determine umbilical cord blood levels of and correlations among IL-33, TSLP, and IgE and (ii) identify statistical associations between maternal and infant characteristics and elevated cord blood levels of IL-33, TSLP, and IgE. Given the lack of evidence explaining the higher prevalence of allergic diseases, including asthma, among boys [@b16] a secondary objective was to determine whether these statistical associations differed by infant sex.

Method
======

Study design
------------

Biospecimens and data for this study were from the Maternal-Infant Research on Environmental Chemicals (MIREC) Study Biobank, a trans-Canada cohort study of 2001 pregnant women from 10 Canadian cities during 2008--11, as previously described [@b17]. Briefly, women were eligible for inclusion if they were \<14 wk gestation at time of recruitment, ≥18 yr of age, able to communicate in French or in English, and planning on delivering at a local hospital [@b17]. Participants included in the present investigation were mothers who had a singleton, live, term birth (≥37 wk) and a cord blood sample suitable for analysis. Cord blood samples (n = 5) with immunoglobulin A (IgA) levels ≥10 μg/ml were excluded to minimize the possibility of contamination from maternal blood [@b18]. Ethical approval was obtained from Health Canada, Sainte Justine\'s Hospital (Montreal, QC, Canada), and the IWK Health Centre (Halifax, NS, Canada).

Data collection
---------------

Trained research staff interviewed participants during the first and third trimester to obtain data on maternal lifestyle, medical history, demographics, and ambient environment characteristics. Clinical data on the mother and infant were obtained from chart review.

Immune system biomarkers were measured in the plasma of umbilical cord blood samples in the Department of Microbiology & Immunology, Dalhousie University, Halifax, NS using specific ELISAs. TSLP concentrations were assessed using a commercial kit (Biolegend, San Diego, CA, USA). IL-33 concentrations were assessed an R&D systems duoset (Minneapolis, MN, USA). ELISA kits (EBioscience, San Diego, CA, USA) were also used to assess both total IgE and IgA concentrations. ELISA assays were performed according to manufacturer\'s instructions with the exception that plates were coated with sodium bicarbonate buffer (pH 8.3--8.5) and blocked with 2% BSA in PBS instead of manufacturer\'s coating and blocking buffers. Extended standard curves were used to improve sensitivity. The interassay and intra-assay coefficients of variation (CVs) for IL-33 were 5.9% and 11.3%, respectively; for TSLP interassay and intra-assay, CVs were 6.0% and 8.1%, respectively. The interassay and intra-assay CVs were 3.2% and 6.5%, respectively, for IgE and 5.2% and 10.4%, respectively, for IgA. Serial dilutions of both TSLP and IL-33 in spiked samples were tested and observed to be internally consistent. Both assays exhibited linearity in concentrations of serial dilutions.

Statistical analysis
--------------------

Ambient maternal exposures, reproductive, and medical history characteristics as well as newborn characteristics determined *a priori* to be potential determinants of childhood allergic diseases were included in statistical models [@b19]. Maternal age, household income, self-reported exposure to street traffic, parental smoking, ownership of at least one pet, pre-pregnancy body mass index (BMI) [@b20], maternal allergy, parity, mode of delivery, infant sex, and fetal growth were included in the analysis. The association between maternal fever and infection and elevated biomarker concentrations was examined to assess the potential influence of underlying infection-related processes.

Descriptive statistics for the immune system biomarkers were calculated using medians and interquartile ranges (IQR) due to the skewed distribution of the data. In the calculation of the median, samples below the limit of detection (LOD) were extrapolated from the ELISA curve. Spearman correlation coefficients (SCC) were calculated to determine correlation among continuous measures of TSLP, IL-33, and IgE. Due to the high percentage of samples below the (LOD), each biomarker was categorized into a binary variable. The 80th percentile was used to identify the subset of samples with elevated concentrations of TSLP (572 pg/ml) and IL-33 (942 pg/ml) due to the lack of established cutoff points. This cutoff was used instead of the detection limit because the objective was to assess prenatal predictors of elevated cytokine levels. A composite variable was developed to identify samples with elevated concentrations of both TSLP and IL-33. A sensitivity analysis was conducted to examine TSLP and IL-33 as binary variables defined at their respective LODs (TSLP = 63 pg/ml; IL-33 = 45 pg/ml). The cutoff percentile for IgE was defined at 1.2 ng/ml (0.5 kU/l) [@b21],[@b22], a cutoff point previously used in studies of cord blood IgE [@b5],[@b7]. A bivariate analysis of all prenatal predictors and elevated IL-33, TSLP, and IgE was conducted using logistic regression. All variables with a p-value of \<0.1 in this analysis were assessed for inclusion in a multivariate logistic regression model using stepwise logistic regression with a p-value criteria of 0.1 for variable inclusion and retention. Variables were entered into the model as they are depicted in Table[1](#tbl1){ref-type="table"}. To assess whether the relationship between prenatal predictors and immune system biomarkers differed by infant sex, the p-value of the product term was assessed and sex-stratified analysis were conducted. All analyses were performed using [sas]{.smallcaps} software v. 9.2 (SAS Institute, Cary, NC, USA).

###### 

Unadjusted odds ratios (95% CI) of prenatal predictors and umbilical cord blood levels of high TSLP (≥80%) (pg/ml), IL-33 (≥80%) (pg/ml), and IgE (≥0.5 kU/l), MIREC Study, Canada, 2008--11

  Characteristic                                           N (%)         High TSLP OR (95% CI)                             High IL-33 OR (95% CI)                            High IL-33 and TSLP OR (95% CI)                   High IgE OR (95% CI)
  -------------------------------------------------------- ------------- ------------------------------------------------- ------------------------------------------------- ------------------------------------------------- -------------------------------------------------
  Maternal demographic, reproductive and medical history                                                                                                                                                                       
   Maternal age                                                                                                                                                                                                                
    ≤24                                                    60 (4.8)      1.0                                               1.0                                               1.0                                               1.0
    25--29                                                 270 (21.5)    1.0 (0.5--1.9)                                    0.7 (0.4--1.3)                                    0.8 (0.4--1.5)                                    0.8 (0.4--1.6)
    30--34                                                 453 (36.0)    0.7 (0.4--1.9)                                    0.7 (0.4--1.2)                                    0.6 (0.3--1.2)                                    0.7 (0.4--1.4)
    ≥35                                                    476 (37.8)    0.8 (0.4--1.5)                                    0.7 (0.4--1.2)                                    0.7 (0.3--1.3)                                    0.6 (0.3--1.1)[\*](#tf1-2){ref-type="table-fn"}
   Pre-pregnancy BMI                                                                                                                                                                                                           
    Underweight (\<18.5)                                   27 (2.3)      1.0                                               1.0                                               1.0                                               1.0
    Normal (18.5--24.9)                                    719 (60.5)    1.1 (0.4--3.0)                                    1.1 (0.4--2.9)                                    1.1 (0.4--3.3)                                    0.5 (0.2--1.2)
    Overweight (25--29.9)                                  272 (22.9)    1.1 (0.4--3.1)                                    1.1 (0.4--3.0)                                    1.1 (0.4--3.3)                                    0.6 (0.2--1.5)
    Obese (≤30)                                            171 (14.4)    0.9 (0.3--2.5)                                    1.0 (0.3--2.8)                                    0.9 (0.3--2.8)                                    0.4 (0.2--1.1)
   Maternal allergy[†](#tf1-3){ref-type="table-fn"}                                                                                                                                                                            
    No                                                     1205 (95.7)   1.0                                               1.0                                               1.0                                               1.0
    Yes                                                    54 (4.3)      1.9 (1.1--3.4)[\*](#tf1-2){ref-type="table-fn"}   1.8 (1.0--3.2)[\*](#tf1-2){ref-type="table-fn"}   2.1 (1.1--3.9)[\*](#tf1-2){ref-type="table-fn"}   1.5 (0.8--3.0)
   Parity                                                                                                                                                                                                                      
    Nulliparous                                            527 (41.9)    1.0                                               1.0                                               1.0                                               1.0
    Primiparous                                            513 (40.8)    1.1 (0.8--1.5)                                    1.1 (0.8--1.5)                                    1.3 (0.9--1.8)                                    0.9 (0.7--1.3)
    Multiparous                                            217 (17.3)    0.7 (0.4--1.0)                                    0.7 (0.5--1.1)                                    0.7 (0.4--1.1)[\*](#tf1-2){ref-type="table-fn"}   1.0 (0.7--1.6)
   Mode of delivery                                                                                                                                                                                                            
    Spontaneous                                            900 (71.5)    1.0                                               1.0                                               1.0                                               1.0
    Cesarean                                               359 (25.5)    1.0 (0.7--1.3)                                    1.0 (0.7--1.4)                                    0.9 (0.7--1.3)                                    1.0 (0.7--1.4)
   Household income                                                                                                                                                                                                            
    ≤30,000                                                90 (7.4)      1.0                                               1.0                                               1.0                                               1.0
    30,001--50,000                                         117 (9.7)     1.7 (0.8--3.3)                                    2.8 (1.3--6.0)[\*](#tf1-2){ref-type="table-fn"}   2.6 (1.1--5.8)[\*](#tf1-2){ref-type="table-fn"}   1.2 (0.6--2.4)[\*](#tf1-2){ref-type="table-fn"}
    50,001--100,000                                        515 (42.6)    1.0 (0.5--1.9)                                    1.5 (0.8--3.0)                                    1.5 (0.7--3.1)                                    0.7 (0.4--1.2)
    \>100,000                                              488 (40.3)    1.2 (0.7--2.0)                                    1.9 (0.6--3.6)                                    1.8 (0.9--3.7)                                    0.7 (0.4--1.2)
  Ambient maternal exposures                                                                                                                                                                                                   
   Traffic[‡](#tf1-4){ref-type="table-fn"}                                                                                                                                                                                     
    Light                                                  860 (68.4)    1.0                                               1.0                                               1.0                                               1.0
    Medium                                                 250 (19.9)    0.8 (0.6--1.2)                                    0.9 (0.7--1.4)                                    0.9 (0.6--1.3)                                    1.0 (0.7--1.5)
    Heavy                                                  147 (11.7)    1.3 (0.9--2.0)                                    1.5 (1.0--2.2)                                    1.7 (1.1--2.6)[\*](#tf1-2){ref-type="table-fn"}   1.7 (1.1--2.6)[\*](#tf1-2){ref-type="table-fn"}
   Parental smoking[§](#tf1-5){ref-type="table-fn"}                                                                                                                                                                            
    No                                                     1009 (80.1)   1.0                                               1.0                                               1.0                                               1.0
    Yes                                                    250 (19.9)    1.1 (0.88--1.5)                                   1.2 (0.9--1.7)                                    1.2 (0.8--1.7)                                    1.2 (0.9--1.8)
   Pet ownership                                                                                                                                                                                                               
    No                                                     560 (44.5)    1.0                                               1.0                                               1.0                                               1.0
    Yes                                                    699 (55.5)    1.1 (0.8--1.5)                                    1.1 (0.8--1.4)                                    1.0 (0.7--1.3)                                    0.8 (0.6--1.1)
  Infant characteristics                                                                                                                                                                                                       
   Infant sex                                                                                                                                                                                                                  
    Male                                                   673 (53.5)    1.0                                               1.0                                               1.0                                               1.0
    Female                                                 585 (46.5)    1.2 (0.9--1.6)                                    1.0 (0.8--1.3)                                    1.1 (0.8--1.5)                                    0.8 (0.6--1.0)[\*](#tf1-2){ref-type="table-fn"}
   Birth weight (g)                                                                                                                                                                                                            
    \<3000                                                 138 (11.0)    1.0                                               1.0                                               1.0                                               1.0
    3000 to \<3500                                         479 (38.1)    0.9 (0.6--1.3)                                    1.0 (0.6--1.8)                                    1.1 (0.7--1.9)                                    1.0 (0.6--1.7)
    3500 to \<4000                                         450 (35.7)    1.3 (0.8--2.1)                                    1.2 (0.8--2.0)                                    1.4 (0.8--2.4)                                    1.3 (0.8--2.2)
    ≥4000                                                  192 (15.3)    1.9 (1.1--3.2)[\*](#tf1-2){ref-type="table-fn"}   1.7 (1.0--3.0)[\*](#tf1-2){ref-type="table-fn"}   2.1 (1.2--3.9)[\*](#tf1-2){ref-type="table-fn"}   1.2 (0.6--2.2)

BMI, body mass index; MIREC, Maternal-Infant Research on Environmental Chemicals; TSLP, thymic stromal lymphopoietin; IL-33, interleukin-33; IgE, immunoglobulin E.

p-value \< 0.1.

Defined by the self-reported use an anti-allergen medication.

Defined as self-reported residential street traffic intensity.

Defined as yes if either the mother or father smoked during the pregnancy.

Results
=======

Of the 2001 women recruited into MIREC, 18 withdrew and asked that their data and biospecimens be destroyed. Of the remaining 1983 subjects, 1363 women had provided a cord blood sample. Of these 1363 samples, 104 were excluded for a high IgA concentration, pre-term birth (\<37 wk), multiple birth, or samples that were inadequate for analysis, leaving 1259 subjects for this study.

The percentages of TSLP, IL-33, and IgE samples above the LOD were 42%, 52%, and 18%, respectively (dot plots depicted in Figs S1--S3). The median and IQR of the IL-33 (pg/ml), TSLP (pg/ml), and IgE (ng/ml) were 50.7 (45.0--500.5), 63.0 (63.0--322.4), and 0.30 (0.0--2.4), respectively. The percentage of samples with IgE concentrations that exceeded 1.2 ng/ml was 16%. The correlation between TSLP and IL-33 (SCC = 0.75, p \< 0.0001) was stronger than the correlations between IgE and either TSLP (SCC = 0.21) or IL-33 (SCC = 0.14). Eighty percent of samples that were categorized as having a high TSLP value had a high IL-33 value. Maternal allergy and highest birth weight were both positively associated with elevated TSLP concentrations in a bivariate analysis (p-value of \<0.1) and elevated IL-33. Household income was also significantly associated with elevated IL-33 although there was no apparent dose--response relationship between these two variables. The following variables were positively associated with jointly elevated TSLP and IL-33: self-reported heavy exposure to street traffic, maternal allergy, and elevated birth weight. Household income and parity were associated with this outcome, but no clear trend of the direction of the association was observed (Table[1](#tbl1){ref-type="table"}). Maternal age, household income, and female sex were inversely associated with elevated IgE, whereas traffic exposure was positively associated with elevated IgE. There were no significant associations between either maternal fever or maternal infection and any of the tested biomarkers (data not shown).

Birth weight was the only variable that remained in the multivariate analysis of elevated IL-33, while maternal allergy and birth weight remained in the analysis of elevated TSLP (Table[2](#tbl2){ref-type="table"}). Maternal allergy (OR = 2.1; 95% CI: 1.1--3.9), self-reported exposure to traffic (heavy traffic OR = 1.8; 95% CI: 1.2--2.8), and birth weight (≥4000 g OR = 2.2; 95% CI: 1.2--4.0) were significantly and positively associated with jointly elevated TSLP and IL-33 in the multivariate analysis. A significant dose--response relationship between birth weight (test for trend p = 0.001) and jointly elevated TSLP and IL-33 was observed (Table[2](#tbl2){ref-type="table"}). The relationships between birth weight, traffic, and maternal allergy and jointly elevated TSLP and IL-33 did not differ by sex as evidenced by a non-statistically significant product term and comparable magnitudes of effects (Figs [1](#fig01){ref-type="fig"}-[3](#fig03){ref-type="fig"}). In the sensitivity analysis using LOD rather than the 80th percentile, birth weight was the only variable significantly associated with detectable concentrations of either TSLP or IL-33. In the multivariate IgE model, maternal age (test for trend p-value = 0.02) and female sex were inversely related to elevated IgE levels. The association between maternal age and IgE did not differ by infant sex.

###### 

Adjusted odds ratios of prenatal predictors and umbilical cord blood levels of high IL-33 (≥80%) (pg/ml), TSLP (≥80%) (pg/ml), and IgE (≥0.5 kU/l), MIREC Study, Canada, 2008--11[\*](#tf2-2){ref-type="table-fn"}

  Characteristics                                          High IL-33 OR (95 % CI)   High TSLP OR (95 % CI)   High IL-33 and TSLP OR (95% CI)   High IgE OR (95% CI)
  -------------------------------------------------------- ------------------------- ------------------------ --------------------------------- ----------------------
  Maternal demographic, reproductive and medical history                                                                                        
   Maternal age                                                                                                                                 
    ≤24                                                    --                        --                       --                                1.0
    25--29                                                 0.8 (0.4--1.6)                                                                       
    30--34                                                 0.7 (0.4--1.4)                                                                       
    ≥35                                                    0.5 (0.3--1.0)                                                                       
    Test for trend                                         0.02                                                                                 
   Maternal allergy                                                                                                                             
    No                                                     --                        1.0                      1.0                               --
    Yes                                                    1.8 (1.0--3.3)            2.1 (1.1--3.9)                                             
  Ambient maternal exposures                                                                                                                    
   Traffic                                                                                                                                      
    Light                                                  --                        --                       1.0                               --
    Medium                                                 0.9 (0.6--1.3)                                                                       
    Heavy                                                  1.8 (1.2--2.8)                                                                       
    Test for trend                                         0.04                                                                                 
  Infant characteristics                                                                                                                        
   Sex                                                                                                                                          
    Male                                                   --                        --                       --                                1.0
    Female                                                 0.8 (0.6--1.0)                                                                       
   Birth weight (g)                                                                                                                             
    \<3000                                                 1.0                       1.0                      1.0                               --
    3000 to \<3500                                         1.0 (0.6--1.5)            0.9 (0.6--1.3)           1.1 (0.6--1.9)                    
    3500 to \<4000                                         1.2 (0.8--2.0)            1.3 (0.8--2.1)           1.5 (0.8--2.6)                    
    ≥4000 g                                                1.7 (1.0--3.0)            1.9 (1.1--3.2)           2.2 (1.2--4.0)                    
    Test for trend                                         0.006                     0.001                    0.001                             

MIREC, Maternal-Infant Research on Environmental Chemicals; TSLP, thymic stromal lymphopoietin; IL-33, interleukin-33; IgE, immunoglobulin E.

Models adjusted for those variables identified as having p \< 0.1 based on findings in Table [2](#tbl2){ref-type="table"}. IL-33 model adjusted for birth weight, TSLP model adjusted for allergy and birth weight, IL-33/TSLP model adjusted for allergy, traffic, and birth weight, IgE model adjusted for maternal age and sex.

![Adjusted odds ratios (95% CI) of birth weight and elevated thymic stromal lymphopoietin (TSLP) and IL-33 stratified by infant sex.](pai0026-0161-f1){#fig01}

![Adjusted odds ratios (95% CI) of traffic exposure and elevated thymic stromal lymphopoietin (TSLP) and IL-33 stratified by infant sex.](pai0026-0161-f2){#fig02}

![Adjusted odds ratios (95% CI) of maternal allergy and elevated thymic stromal lymphopoietin (TSLP) and IL-33 stratified by infant sex.](pai0026-0161-f3){#fig03}

Discussion
==========

In this prospective cohort study of Canadian women, we observed several novel findings. First, IL-33 and TSLP levels were detectable at birth and highly correlated with each other. Second, elevated levels of the composite TSLP and IL-33 variable were significantly and positively associated with maternal allergy, birth weight, and self-reported exposure to traffic. The magnitudes of these associations were greater in the joint IL-33 TSLP model than in the independent cytokine models. Further, cord blood IgE levels were inversely associated with maternal age and female sex, but not the presence of maternal allergy, in a multivariate model.

The observed strong correlation between TSLP and IL-33 provides preliminary evidence that TSLP and IL-33 may be operating in a dependent manner in the developing immune system. These speculations require further investigation to clarify whether the observed levels of TSLP and IL-33 persist into childhood and promote inflammatory responses that manifest as allergic disease. The link with higher birth weight might also suggest an early inflammatory component involving TSLP and IL-33 that is linked to adiposity. Although birth weight is an imperfect surrogate for adiposity, high birth weight has been consistently associated with an increased risk of childhood obesity independent of infant sex [@b23]. The observed dose--response relationship between birth weight and elevated cytokine levels in the primary and sensitivity analysis is consistent with evidence of common phenotypes among both childhood asthma and obesity [@b24]. The observed association raises the question of whether a childhood asthma--obesity association is rooted in fetal development.

Although, to our knowledge, there are no published investigations of TSLP or IL-33 levels in cord blood, the present findings are consistent with evidence regarding atopic disease determinants. The observed statistically significant association between maternal allergy and joint elevation of levels of TSLP and IL-33 suggests that maternal allergy has an influence on these biomarkers that is detectable at birth. This finding builds upon evidence of a genetic component to childhood allergic disease [@b25]. The lack of significant association in the sensitivity analysis may indicate that the subset of infants with elevated cytokine levels have a different risk profile that than those with detectable concentrations.

The finding between self-reported street traffic exposure and jointly elevated TSLP and IL-33 levels, although lacking a strong dose--response relationship, is supported by toxicological evidence that air pollution, specifically diesel exhaust and particulate matter, can induce inflammatory processes including epithelial cell production of TSLP [@b26]. The lack of dose--response relationship may be explained by the potential challenge in differentiating between 'low' and 'medium' levels of traffic exposure and resulting exposure misclassification [@b27]. Given the coherence between the present results and the literature on allergic disease determinants, further investigation is warranted to elucidate: (i) the mechanisms underlying the observed statistical associations; (ii) the long-term implications of elevated cord blood levels of TSLP and IL-33, and (iii) whether immune system sequelae are enhanced when TSLP and IL-33 are elevated.

The present findings of an inverse relation between elevated cord blood IgE and both maternal age and female sex have also been reported in a US-based study [@b28]. This study reported that residence in low-income areas, Hispanic ethnicity, and maternal total IgE were associated with elevated cord blood IgE levels [@b28]. The MIREC study did not measure maternal total IgE as it was not part of the original cohort analyses. Moreover, the MIREC study population is primarily urban, Caucasian and of higher household income levels than the general population [@b17]. A biologic mechanism for the findings in regard to maternal age remains to be identified. The inverse relationship between females and IgE motivates investigation into how early life development of allergic disease differs between girls and boys.

The present study benefited from the relatively large sample size and comparatively rich covariate data. The sample size exceeds any previous analysis of either TSLP or IL-33 in humans. The MIREC study population represents multiple geographic regions within the country. We were able to restrict the analysis to cord blood samples not contaminated by maternal blood by excluding samples with elevated IgA concentrations. We were also able to rule out the role of underlying inflammatory responses in promoting high biomarker concentrations. This study was, however, subject to at least four limitations common to observational studies. First, as data on childhood allergic diagnoses were not available in the MIREC study, we were not able to examine these outcomes. Second, both maternal allergy and traffic were self-reported. Given that the estimated allergy prevalence in the MIREC study (4.3%) is lower than other national estimates of allergy medication use (4--9%) [@b29], it is unlikely that any resulting bias from the self-reported nature of the variable overestimated allergy prevalence. Furthermore, the available data on traffic exposure in the MIREC study does not capture time or duration of exposure. Third, the study sample included higher income, more educated women, who were less likely to smoke than the general population. Although this potential selection bias is unlikely to have influenced the observed associations, which operate independently of socioeconomic status, it does restrict examination of certain prenatal characteristics. Fourth, the influence of residual confounding on the observed associations from unmeasured variables such as maternal stress or vitamin D cannot be ruled out. There are also unmeasured factors, such as endogenous corticosteroids and other inflammatory cytokines, which could modify IL-33 and TSLP simultaneously. For example, the epithelial-derived cytokine IL-25 (IL-17E) and IL-17 family member has received attention for interacting with IL-33 and TSLP to enhance inflammatory responses [@b9].

In conclusion, the present findings suggest that neonates with elevated cord blood levels of TSLP and IL-33 may represent an immunologically distinct subset. These cytokines were associated with maternal and infant characteristics that reflect underlying inflammation and/or increased risk of allergic disease development. Thus, cord blood levels of TSLP and IL-33 warrant further investigation as potential predictive factors for inflammatory and allergic disease. Given what is known regarding the integral role of TSLP and IL-33 in allergic disease and inflammatory processes, the present findings also raise interesting questions regarding *in utero* coordinated regulation of these cytokines and motivate further research on this topic.
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**Figure S1.** Dot plot of log10 IgE concentrations in cord blood plasma samples (n = 1254).

**Figure S2.** Dot plot of log10 TSLP concentrations in cord blood plasma samples (n = 1254).

**Figure S3.** Dot plot of log10 IL-33 concentrations in cord blood plasma samples (n = 1254).
